Abstract 501: Endothelin-1 Expression Is Dependent On The Stability Of Endothelial Glycocalyx Heparan Sulfate
Santiago A Rivero,Solomon A Mensah
DOI: https://doi.org/10.1161/atvb.43.suppl_1.501
2023-05-01
Abstract:Introduction: Endothelin-1 (ET-1) is a vasoconstrictor produced by the vascular endothelium [1]. It binds to endothelial B receptor(ETB) on the endothelial cells(EC) [2]. Increased ET-1 has been observed in the EC of patients with moderate to severe hypertension [3]. Studies suggest that the EC cytoskeletal disruptions could mediate its production[4,5,6]. ETB is a plasma membrane bound receptor present in the EC surface with EC glycocalyx (GCX) [7,8]. GCX is flow sensitive and consists of several transmembrane solid core proteins [10,11,12]. Linked to the core protein chains include heperan sulfate (HS) [12]. GCX HS and ETB are located in the surface of the EC and are both flow sensitive. We hypothesize that the shear stress induced upregulation of the GCX HS could lead to expression of ETB which will trigger the release of ET1. Methods: Human Lung Microvascular Endothelial cells (HLMVEC) were cultured until 70-80% confluence. To mimic disease progression the GCX were degraded with Heparinase III which targets the HS component of the GCX. Immunostaining was used to determine the expression of GCX HS, ETB and ET-1. Results: Data revealed that the degradation of GCX HS resulted in the significant decrease in the expression of ETB. Conversely, the removal of GCX HS caused a significant increase in the expression of ET-1. Discussion: The preliminary results from, immunostaining reveals a potential co-participation of GCX HS and ETB in the expression of ET-1. References: [1] Sutton. G. et al, American Journal of Hypertension, 32:813-815, 2019.[2] Dhaun, N. et al, Hypertension , 52:452-459, 2008.[3] Morawietz, H. et al , J Physiol , 525:761-770, 2000.[4] Kuchan, M.J, et al, Am J Physiol , 264:H150-H156, 1993.[5] Morita, T. et al, J Clin Invest , 92:1706-1712, 1993.[6] Pollock, D.M. et al, Hypertension , 48:211-212, 2006.[7] Perez-Aguilar, S. et al, Am J Physiol Heart Circ Physiol , 306:H699-H708, 2014.[8] Ebong, E.E. et al., Integr Biol (Camb) , 6:338-347, 2014.[9] Tarbell, J.M. et al., Sci Signal , 1:8, 2008.[10] Fu, B.M et al, Wiley Interdiscip Rev Syst Biol Med , 5:381-390, 2013.[11] Reitsma, S. et al, Pflugers Archiv : European journal of physiology , 454:345-359, 2007.[12] Bartosch, A.M.W. et al, Sci Rep , 11:11386, 2021
peripheral vascular disease,hematology